.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076792

« Back to Dashboard
NDA 076792 describes METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE, which is a drug marketed by Sun Pharm Inds, Alembic Pharms Ltd, and Mylan, and is included in three NDAs. It is available from six suppliers. Additional details are available on the METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE profile page.

The generic ingredient in METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; metoprolol tartrate. There are thirty-one drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.

Summary for NDA: 076792

Tradename:
METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
Applicant:
Mylan
Ingredient:
hydrochlorothiazide; metoprolol tartrate
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 076792

Ingredient-typeThiazides
Mechanism of ActionAdrenergic beta-Antagonists
Physiological EffectIncreased Diuresis

Suppliers and Packaging for NDA: 076792

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; metoprolol tartrate
TABLET;ORAL 076792 ANDA Mylan Pharmaceuticals Inc. 0378-0424 0378-0424-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0424-01)
METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; metoprolol tartrate
TABLET;ORAL 076792 ANDA Mylan Pharmaceuticals Inc. 0378-0434 0378-0434-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0434-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG;50MG
Approval Date:Aug 20, 2004TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG;100MG
Approval Date:Aug 20, 2004TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG;100MG
Approval Date:Aug 20, 2004TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc